A detailed history of Palo Alto Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Palo Alto Wealth Advisors, LLC holds 712 shares of LLY stock, worth $539,261. This represents 0.21% of its overall portfolio holdings.

Number of Shares
712
Previous 692 2.89%
Holding current value
$539,261
Previous $535 Million 0.55%
% of portfolio
0.21%
Previous 0.19%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$725.72 - $929.72 $14,514 - $18,594
20 Added 2.89%
712 $532 Million
Q4 2024

Feb 14, 2025

BUY
$727.2 - $932.06 $503,222 - $644,985
692 New
692 $535 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $720B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Palo Alto Wealth Advisors, LLC Portfolio

Follow Palo Alto Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Palo Alto Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Palo Alto Wealth Advisors, LLC with notifications on news.